RNA modifications in pulmonary diseases

被引:2
作者
Qian, Weiwei [1 ,2 ]
Yang, Lvying [3 ]
Li, Tianlong [4 ]
Li, Wanlin [5 ]
Zhou, Jian [6 ,7 ]
Xie, Shenglong [8 ]
机构
[1] Sichuan Univ, West China Hosp & Disaster Med, Emergency Dept Emergency Med, Lab Emergency Med, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, Shangjinnanfu Hosp, West China Hosp, Emergency Dept, Chengdu, Sichuan, Peoples R China
[3] First Vet Hosp Sichuan Prov, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China
[5] Shenzhen Third Peoples Hosp, Natl Clin Res Ctr Infect Dis, Shenzhen, Guangdong, Peoples R China
[6] Shenzhen Univ, Sch Biomed Engn, Med Sch, Guangdong Key Lab Biomed Measurements & Ultrasound, Shenzhen, Peoples R China
[7] Shenzhen Univ, Hlth Sci Ctr, Int Canc Ctr, Dept Immunol, Shenzhen, Guangdong, Peoples R China
[8] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Thorac Surg, Chengdu, Sichuan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 05期
基金
中国国家自然科学基金;
关键词
pulmonary diseases; functions of RNA modifications; RNA modification database; RNA modifications; SINGLE-NUCLEOTIDE-RESOLUTION; MESSENGER-RNA; LUNG-CANCER; M(6)A METHYLTRANSFERASE; N-6-METHYLADENOSINE RNA; SEQUENCING TECHNOLOGIES; COMPREHENSIVE DATABASE; GENE-EXPRESSION; NONCODING RNAS; NUCLEAR-RNA;
D O I
10.1002/mco2.546
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Threatening public health, pulmonary disease (PD) encompasses diverse lung injuries like chronic obstructive PD, pulmonary fibrosis, asthma, pulmonary infections due to pathogen invasion, and fatal lung cancer. The crucial involvement of RNA epigenetic modifications in PD pathogenesis is underscored by robust evidence. These modifications not only shape cell fates but also finely modulate the expression of genes linked to disease progression, suggesting their utility as biomarkers and targets for therapeutic strategies. The critical RNA modifications implicated in PDs are summarized in this review, including N6-methylation of adenosine, N1-methylation of adenosine, 5-methylcytosine, pseudouridine (5-ribosyl uracil), 7-methylguanosine, and adenosine to inosine editing, along with relevant regulatory mechanisms. By shedding light on the pathology of PDs, these summaries could spur the identification of new biomarkers and therapeutic strategies, ultimately paving the way for early PD diagnosis and treatment innovation. This review presents the crucial involvement of RNA epigenetic modifications (m6A, m1A, m5C, Psi, m7G, and A-to-I editing) in pulmonary diseases, spanning chronic conditions to lung cancer. Focusing on their impact on disease regulation as promising biomarkers and therapeutic targets. Additionally, essential databases and tools are summarized, fostering insights for clinical research of pulmonary disease to improve diagnosis and treatment. m6A, N6-methylation of adenosine; m1A, N1-methylation of adenosine; m5C, 5-methylcytosine; Psi, pseudouridine; m7G, 7-methylguanosine; A-to-I, adenosine to inosine; COPD, chronic obstructive pulmonary disease; IPF, interstitial lung disease, idiopathic pulmonary fibrosis; ARDS, acute respiratory distress syndrome; PTB, pulmonary tuberculosis; RMBase, RNA Modification Base Database; NGS, next-generation sequencing; LC-MS, liquid chromatography mass spectrometer; TLC, thin layer chromatography; RIP, RNA immunoprecipitation. # image
引用
收藏
页数:23
相关论文
共 247 条
[41]   RETRACTED: m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis (Retracted Article) [J].
Deng, Meng-Sheng ;
Chen, Kui-Jun ;
Zhang, Dong-Dong ;
Li, Guan-Hua ;
Weng, Chang-Mei ;
Wang, Jian-Min .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
[42]   RNA N6-methyladenosine modification in cancers: current status and perspectives [J].
Deng, Xiaolan ;
Su, Rui ;
Weng, Hengyou ;
Huang, Huilin ;
Li, Zejuan ;
Chen, Jianjun .
CELL RESEARCH, 2018, 28 (05) :507-517
[43]   5-methylcytosine mediates nuclear export of mRNA [J].
Dominissini, Dan ;
Rechavi, Gideon .
CELL RESEARCH, 2017, 27 (06) :717-719
[44]   Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq [J].
Dominissini, Dan ;
Moshitch-Moshkovitz, Sharon ;
Schwartz, Schraga ;
Salmon-Divon, Mali ;
Ungar, Lior ;
Osenberg, Sivan ;
Cesarkas, Karen ;
Jacob-Hirsch, Jasmine ;
Amariglio, Ninette ;
Kupiec, Martin ;
Sorek, Rotem ;
Rechavi, Gideon .
NATURE, 2012, 485 (7397) :201-U84
[45]   Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing [J].
Dong, Jingsi ;
Li, Bingjie ;
Lin, Dan ;
Zhou, Qinghua ;
Huang, Depei .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[46]   Overcoming cellular barriers for RNA therapeutics [J].
Dowdy, Steven F. .
NATURE BIOTECHNOLOGY, 2017, 35 (03) :222-229
[47]   YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex [J].
Du, Hao ;
Zhao, Ya ;
He, Jinqiu ;
Zhang, Yao ;
Xi, Hairui ;
Liu, Mofang ;
Ma, Jinbiao ;
Wu, Ligang .
NATURE COMMUNICATIONS, 2016, 7
[48]   MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA [J].
Du, Minjun ;
Zhang, Yanjiao ;
Mao, Yousheng ;
Mou, Juwei ;
Zhao, Jun ;
Xue, Qi ;
Wang, Dali ;
Huang, Jinfeng ;
Gao, Shugeng ;
Gao, Yushun .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 482 (04) :582-589
[49]   SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function [J].
Du, Yuzhang ;
Hou, Guofang ;
Zhang, Hailong ;
Dou, Jinzhuo ;
He, Jianfeng ;
Guo, Yanming ;
Li, Lian ;
Chen, Ran ;
Wang, Yanli ;
Deng, Rong ;
Huang, Jian ;
Jiang, Bin ;
Xu, Ming ;
Cheng, Jinke ;
Chen, Guo-Qiang ;
Zhao, Xian ;
Yu, Jianxiu .
NUCLEIC ACIDS RESEARCH, 2018, 46 (10) :5195-5208
[50]   Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties [J].
Elhardt, Winfried ;
Shanmugam, Raghuvaran ;
Jurkowski, Tomasz P. ;
Jeltsch, Albert .
BIOCHIMIE, 2015, 112 :66-72